The purpose for this annual Alzheimer’s Drug Discovery Foundation (ADDF) conference is to accelerate the development of innovative treatments for Alzheimer’s disease, related dementias and cognitive aging.
The two-day meeting is organized around four sub-topics: Neuroinflammation; Neuroprotection and Neural Regeneration; Epigenetics and Cognitive Enhancing; and Misfolded Proteins and Proteostasis.
Attendees will see the diverse cutting-edge approaches ADDF scientists are undertaking and have opportunities for networking and partnership discussions with academic, industry, and foundation thought leaders.